Hisamitsu Pharmaceutical Co.,Inc.
https://global.hisamitsu/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hisamitsu Pharmaceutical Co.,Inc.
Finance Watch: VC Mega-Rounds Are Alive And Well
Private Company Edition: Also, Catalio closed a $381m venture capital fund and OrbiMed’s SEC filings indicate it is in the process of raising $4.75bn across three new funds. Dianthus launched with $100m and Tubulis closed a $63m series B round.
ProQR Remains Confident In Pipeline After Sepofarsen Flop, Analysts Not So Much
The company is pinning hopes on its Usher syndrome and retinitis pigmentosa programs, but the disconnect between Phase I/II success and Phase II/III failure dented analysts’ enthusiasm.
Finance Watch: Three Newly Public Companies Face Mixed Reception In Early Trading
Also, two more health care-focused SPACs went public, Centessa obtained up to $300m in debt, three new venture capital funds launched and Intergalactic debuted with a $75m series A round.
IPO Update: Average Return Turns Negative For Newly Public Biopharma Firms
With 88 initial public offerings in the US through the end of the third quarter of 2021, the biopharma industry is two IPOs ahead of the full-year 2020 total, but with an average return of -4% momentum may slow.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- OTC, Consumer
-
Drug Delivery
- Transdermal
- Other Names / Subsidiaries
-
- CRCC Media Co.,Ltd. (Fukuoka)
- Saga City-Vision Co.,Ltd. (Saga)
- Taiyo Co.,Ltd (Saga)
- Kyudo Co.,Ltd (Saga)
- Hisamitsu Agency Co.,Ltd. (Fukuoka)
- Hisamitsu U.S., Inc.
- Hisamitsu America, Inc.
- Noven Pharmaceuticals, Inc.
- Hisamitsu Farmaceutica do Brasil Ltda.
- Hisamitsu UK Ltd.
- Hisamitsu Italia S.r.l.
- Hisamitsu Vietnam Pharmaceutical Co.,Ltd.
- Hisamitsu Pharmaceutical(China)Co.,Ltd.
- Hisamitsu Pharmaceutical Technology Consulting(Beijing) Co.,Ltd.
- Hisamitsu Pharmaceutical (Hong Kong)Co.,Ltd.
- PT. Hisamitsu Pharma Indonesia